159 related articles for article (PubMed ID: 23600329)
1. Restoration of IGFBP-rP1 increases radiosensitivity and chemosensitivity in hormone-refractory human prostate cancer.
Seki M; Teishima J; Mochizuki H; Mutaguchi K; Yasumoto H; Oka K; Nagamatsu H; Shoji K; Matsubara A
Hiroshima J Med Sci; 2013 Mar; 62(1):13-9. PubMed ID: 23600329
[TBL] [Abstract][Full Text] [Related]
2. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer.
Mutaguchi K; Yasumoto H; Mita K; Matsubara A; Shiina H; Igawa M; Dahiya R; Usui T
Cancer Res; 2003 Nov; 63(22):7717-23. PubMed ID: 14633696
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer.
Sprenger CC; Damon SE; Hwa V; Rosenfeld RG; Plymate SR
Cancer Res; 1999 May; 59(10):2370-5. PubMed ID: 10344746
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
[TBL] [Abstract][Full Text] [Related]
5. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
[TBL] [Abstract][Full Text] [Related]
6. Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25.
Sato Y; Chen Z; Miyazaki K
Cancer Sci; 2007 Jul; 98(7):1055-63. PubMed ID: 17465992
[TBL] [Abstract][Full Text] [Related]
7. Restoration of fibroblast growth factor receptor 2IIIb enhances the chemosensitivity of human prostate cancer cells.
Shoji K; Teishima J; Hayashi T; Ohara S; Mckeehan WL; Matsubara A
Oncol Rep; 2014 Jul; 32(1):65-70. PubMed ID: 24839986
[TBL] [Abstract][Full Text] [Related]
8. ProstaCaid inhibits tumor growth in a xenograft model of human prostate cancer.
Jiang J; Loganathan J; Eliaz I; Terry C; Sandusky GE; Sliva D
Int J Oncol; 2012 May; 40(5):1339-44. PubMed ID: 22293856
[TBL] [Abstract][Full Text] [Related]
9. Comparative chemosensitivity of circulating human prostate cancer cells and primary cancer cells.
Menen R; Zhao M; Zhang L; Hassanein MK; Bobek V; Kolostova K; Bouvet M; Hoffman RM
Anticancer Res; 2012 Jul; 32(7):2881-4. PubMed ID: 22753751
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
[TBL] [Abstract][Full Text] [Related]
11. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1.
Plymate SR; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Zhang Y; Oberley LW; Zhong W; Drivdahl R; Oberley TD
Oncogene; 2003 Feb; 22(7):1024-34. PubMed ID: 12592389
[TBL] [Abstract][Full Text] [Related]
12. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction.
Xiao D; Lew KL; Kim YA; Zeng Y; Hahm ER; Dhir R; Singh SV
Clin Cancer Res; 2006 Nov; 12(22):6836-43. PubMed ID: 17121905
[TBL] [Abstract][Full Text] [Related]
13. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer.
Koike H; Ito K; Takezawa Y; Oyama T; Yamanaka H; Suzuki K
Br J Cancer; 2005 Apr; 92(8):1538-44. PubMed ID: 15846301
[TBL] [Abstract][Full Text] [Related]
15. Sodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivo.
Tian J; Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):230-6. PubMed ID: 20615620
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
17. The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma.
Tanaka E; Hashimoto Y; Ito T; Kondo K; Higashiyama M; Tsunoda S; Ortiz C; Sakai Y; Inazawa J; Shimada Y
Clin Cancer Res; 2007 Feb; 13(4):1331-40. PubMed ID: 17317845
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenografts.
Tennant MK; Vessella RL; Sprenger CC; Sikes RA; Hwa V; Baker LD; Plymate SR
Prostate; 2003 Jul; 56(2):115-22. PubMed ID: 12746836
[TBL] [Abstract][Full Text] [Related]
19. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
Miyake H; Chi KN; Gleave ME
Clin Cancer Res; 2000 May; 6(5):1655-63. PubMed ID: 10815883
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin enhances the susceptibility of both androgen-dependent and -independent prostate carcinoma cells to docetaxel.
Liu QJ; Xu XH; Shang DH; Tian Y; Lü WC; Zhang YH
Chin Med J (Engl); 2010 Feb; 123(3):356-60. PubMed ID: 20193259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]